about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmTargeted delivery of therapeutics to endothelium.A peptide isolated by phage display binds to ICAM-1 and inhibits binding to LFA-1.Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling.Role of cell adhesion molecules in inflammatory bowel diseases.Reduction of inner ear inflammation by treatment with anti-ICAM-1 antibody.Late effects of radiotherapy on oral mucosa in humans.
P2860
Q27026630-3ABF84F8-0241-4CD8-9F5E-05D30CA66524Q30475849-C3C86100-E570-4197-B29A-A3B240A3BB95Q36836481-34D5EE2E-5059-40B9-B896-C31FE09014AAQ40884698-19BCE1B6-103F-41D9-8F9A-A706E6B0FB23Q41491309-43EB27FE-8AC3-4D2F-A6D7-1085DA37D48FQ46750863-C52AF1AB-C38C-4245-8DCF-A460F3016136Q52767260-E0391D06-7D9F-402E-BB83-5C89BD5724FE
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Treatment of inflammation with anti-ICAM-1.
@en
type
label
Treatment of inflammation with anti-ICAM-1.
@en
prefLabel
Treatment of inflammation with anti-ICAM-1.
@en
P2093
P1476
Treatment of inflammation with anti-ICAM-1.
@en
P2093
E A Mainolfi
R Rothlein
T K Kishimoto
P304
735-9; discussion 754-62
P356
10.1016/S0923-2494(93)80058-7
P577
1993-11-01T00:00:00Z